Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 108 entries
View as:

Prospective Evaluation of Radiotherapy Using Magnetic Resonance Image Guided Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03727698 Org: User:
Start: 01/11/19 End: 11/30/25 Due: 11/30/26

Triple Negative Breast Cancer Trial

Phase: N/A Priority: Normal
NCT ID: NCT00532727 Org: User:
Start: 01/31/08 End: 03/31/20 Due: 03/31/21

Intensity-Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Decreasing Hearing Loss in Patients Who Have Undergone Surgery for Parotid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01216800 Org: User:
Start: 08/31/08 End: - Due: -

International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study)

Phase: N/A Priority: Normal
NCT ID: NCT02305654 Org: User:
Start: 05/12/17 End: 11/30/27 Due: 11/30/28

Preoperative Imaging in Retroperitoneal Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01902667 Org: User:
Start: 07/31/13 End: 06/30/17 Due: 06/30/18

Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00299286 Org: User:
Start: 06/30/07 End: 08/31/11 Due: 08/31/12

The eValuation of Image Guidance of Stereotactic Body Radiotherapy Using Ultrasound: Assessment in Liver

Phase: N/A Priority: Normal
NCT ID: NCT03592550 Org: User:
Start: 09/30/18 End: 12/31/19 Due: 12/31/20

Evaluation of Clarity Ultrasound Guidance for Prostate Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02388308 Org: User:
Start: 05/15/15 End: 06/18/18 Due: 06/18/19

ATr Inhibitor in Combination With Olaparib/Durvalumab (MEDI4736) in Gynaecological Cancers With ARId1A Loss or no Loss

Phase: N/A Priority: Normal
NCT ID: NCT04065269 Org: User:
Start: 11/27/19 End: 04/30/26 Due: 04/30/27

Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00253409 Org: User:
Start: 05/31/05 End: - Due: -

17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00248521 Org: User:
Start: 10/31/05 End: - Due: -

Utilising CTC Counts to Optimize Systemic Therapy of Metastatic Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03327662 Org: User:
Start: 01/11/17 End: 04/30/20 Due: 04/30/21

Imaging NSCLC Treatment Response to Immunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT02753569 Org: User:
Start: 05/31/16 End: 05/14/20 Due: 05/14/21

Combination Study of AZD5069 and Enzalutamide.

Phase: N/A Priority: Normal
NCT ID: NCT03177187 Org: User:
Start: 11/13/17 End: 11/16/22 Due: 11/16/23

Precision Medicine in the Prostate Cancer Care Pathway

Phase: N/A Priority: Normal
NCT ID: NCT04763317 Org: User:
Start: 02/14/19 End: 12/31/30 Due: 12/31/31

Radiation Therapy or Surgery in Treating Patients Receiving Chemotherapy for Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00867347 Org: User:
Start: 07/31/07 End: 04/30/17 Due: 04/30/18

Combination Study of Antibiotics With Enzalutamide (PROMIZE)

Phase: N/A Priority: Normal
NCT ID: NCT06126731 Org: User:
Start: 11/02/23 End: 06/30/27 Due: 06/30/28

Myeloma Novel Drug Discovery Ver 1.2

Phase: N/A Priority: Normal
NCT ID: NCT05968417 Org: User:
Start: 07/22/20 End: 02/28/35 Due: 02/28/36

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00031850 Org: User:
Start: 03/31/00 End: 05/31/07 Due: 05/31/08

Radiation Therapy in Treating Women With Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00107497 Org: User:
Start: 10/05/04 End: 03/09/17 Due: 03/09/18

Assessing Treatment Response in Breast Cancer With Functional Imaging

Phase: N/A Priority: Normal
NCT ID: NCT02688257 Org: User:
Start: 09/30/10 End: 12/30/17 Due: 12/30/18

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00301925 Org: User:
Start: 12/16/05 End: 09/30/24 Due: 09/30/25

Temozolomide Compared to Procarbazine, Lomustine, and Vincristine in Treating Patients With Recurrent Malignant Glioma

Phase: N/A Priority: Normal
NCT ID: NCT00052455 Org: User:
Start: 10/31/02 End: 09/30/10 Due: 09/30/11

Magnetic Resonance Guided High Intensity Focused Ultrasound (MRgHIFU) for Pain Palliation of Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT03479151 Org: User:
Start: 03/16/18 End: 01/07/21 Due: 01/07/22

A Study of Prostate and pelvIs Versus prOsTate Alone Treatment for Locally Advanced Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01685190 Org: User:
Start: 06/30/11 End: 12/31/19 Due: 12/31/20